Proliferações Melanocíticas de Potencial Maligno Incerto: Um Estudo Retrospetivo de 23 Doentes
Introduction: Diagnostic uncertainty is an inseparable component of medical practice. The dichotomous classification of melanocytic lesions as benign or malignant has been replaced in recent years by a more flexible approach in which diagnostic uncertainty is recognized and accepted.
Methods: In order to characterize the population of melanocytic proliferations of uncertain malignant potential diagnosed at our center between 2007 and 2017, histopathological reports of melanocytic lesions classified, in this period, as either dysplastic or malignant were analyzed.
Results: Twenty-three lesions (4.3%) with borderline histopathological features or uncertain malignant potential were identified. The mean patient age was 34.8 years. Sixteen lesions (69.6%) were observed by a second pathologist. The most frequently performed treatment was wide excision. A sentinel lymph node biopsy was performed on 2 patients, both being negative. The median follow-up time was 22 months, and there was no recurrence of any treated lesion.
Discussion: The controversy of the subject extends from the nature and classification of these lesions to their treatment. In this work we perform a statistical review of the population of melanocytic proliferations of uncertain malignant potential diagnosed in our department.
Elder D, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology. 2004;36:428-34. doi: 10.1080/00313020412331283905
Pusiol T, Piscioli F, Speziali L, Zorzi MG, Morichetti D, Roncati L. Clinical features, dermoscopic patterns, and histological diagnostic model for melanocytic tumors of uncertain malignant potential (MELTUMP). Acta Derma- tovenerol Croat. 2015;23:185-94.
Abraham R, Karakousis G, Acs G, Ziober A, Cerroni L, Mihm M, et al. Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP). Am J Surg Pathol. 2013;37:669- 75. doi: 10.1097/PAS.0b013e318288ff47
Requena C, Requena L, Kutzner H, Yus E. Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol. 2009;31:107-16. doi: 10.1097/ dad.0b013e3181934218
Meyers M, Yeh J, Deal A, Byerly F, Woosley J, Frank J, et al. Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melano- cytic tumors of uncertain malignant potential. J Am Coll
Surg. 2010;211:744-8. doi: 10.1016/j.jamcollsurg.
Lallas A, Kyrgidis A, Ferrara G, Kittler H, Apalla Z, Castagnetti F, et al. Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review. Lancet Oncol. 2014;15:e178-83. doi: 10.1016/S1470-
Piccolo V, Moscarella E, Lallas A, Alfano R, Fer-
rara G, Argenziano G. MELTUMP: how to ma- nage these lesions in the clinical routine. G Ital Dermatol Venereol. 2017;152:266-9. doi: 10.1016/ S1470-2045(13)70608-9
Green R, Taghizadeh R, Lewis C, Lawrence C, Husain A, Ahmed O. Melanocytic tumours of uncertain malig- nant potential (MELTUMPs) - a diagnostic and mana- gement dilemma. Eur J Plast Surg. 2014;38:13-6. doi: 10.1007/s00238-014-1028-3
Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, Kut- zner H, et al. Melanocytic Tumors of Uncertain Malignant Potential: results of a tutorial held at the XXIX Sympo- sium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol. 2010;34:314- 26. doi: 10.1097/PAS.0b013e3181cf7fa0
Copyright (c) 2020 Journal of the Portuguese Society of Dermatology and Venereology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in this journal are Open Access and meet the requirements of funding bodies or academic institutions. Each article published in the Journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). Articles can be read, downloaded, printed, and shared.
Submission of an article for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.
It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Author rights: As an author you (or your employer or institution) have certain rights to reuse your work.
The Journal reserves the right to use plagiarism detection software on any submitted material.